MANGALAM DRUG & CHEM LTD (MANGALAM)

NSE: ₹28.49
BSE: ₹28.70
Stock Performance
Corporate Announcements
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

Disclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR, 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director for second term of 5 years.

2026-06-18 19:09:36
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Disclosure of Voting Results and Scrutinizers Report for Postal ballot pursuant to Regulation 44 (3) of SEBI LODR, 2025 for re-appointment of Mr. Praveen Saxena as an Independent Director for second term of 5 years.

2026-06-18 19:06:35
Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure

Subsequent Disclosure under Regulation 30 part A of Schedule III of SEBI (Listing Obligation and Discloure Requirements) Regulations, 2015 of default of Bank Loan account.

2026-06-17 15:07:35
Compliances-Reg.24(A)-Annual Secretarial Compliance

Submission of Annual Secretarial Compliance Report for the period ended 31st March, 2026

2026-05-25 17:01:36
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report to be filed for the financial year ended March 31, 2026 as per Regulation 24A of SEBI LODR, 2025.

2026-05-25 16:17:15
Announcement under Regulation 30 (LODR)-Newspaper Publication

Disclosure under Regulation 30 of LODR 2015 for newspaper publication regarding the dispatch of Postal Ballot/ E- Voting seeking shareholders approval.

2026-05-19 17:13:38
Dispatch Of Postal Ballot Notice Dated 18.05.2026 By Way Of Remote E- Voting For Taking Shareholders Approval For Reappointment Of Shri Praveen Saxena (Independent Director DIN: 03199264) For Second Term Of 5 Consecutive Years

Disclosure of notice of postal ballot /E- Voting seeking shareholders approval pursuant to Regulation 30 of SEBI LODR, 2015 . for reappointment of Shri Praveen Saxena as an Independent Director DIN: 03199264 of the Company for second term of 5 consective years. The Evoting shall commence from 19.05.2026 (9:00 am) and will end on 17.06.2026 (5:00 pm).

2026-05-18 17:32:52
Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure

Intimation of subsequent default of Bank under Para A sub-paragraph 6 of Schedule III-Subsequent default

2026-05-16 14:47:15
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication for declaration of Annual Financial Results (Consolidated and Standalone) for the quarter and financial year ended March 31, 2026.

2026-05-15 14:35:40
Approval Of Audited Financial Results For The Quarter Ended 31St March, 2026

Approval of Financial Results (Standalone & Consolidated) for the quarter and year ended 31st March, 2026

2026-05-14 18:33:16

Quarterly Financials

Consolidated Standalone
Particulars Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 0.00 97.34 102.24 76.54 79.94 88.71 73.04 57.35 49.54 58.49 67.29
YOY Revenue Growth % - - - - - -8.86% -28.56% -25.07% -38.03% -34.07% -7.87%
Other Income 0.00 0.00 0.05 0.02 0.14 0.14 0.21 0.00 0.03 0.11 0.09
Total Income 0.00 97.34 102.28 76.56 80.08 88.85 73.25 57.35 49.57 58.60 67.38
Total Expenses + 0.00 97.30 98.35 75.97 78.88 87.48 71.61 70.35 62.04 68.43 80.65
Cost of Materials Consumed 0.00 46.65 51.55 40.53 43.40 44.86 41.76 23.33 28.89 37.06 35.51
Employee Benefit Expense 0.00 8.97 11.11 9.57 10.18 10.34 10.50 9.38 7.53 8.39 8.49
Other Expenses 0.00 12.12 20.78 18.37 20.40 18.68 17.01 12.87 11.79 14.46 17.26
Operating Profit 0.00 0.04 3.88 0.56 1.06 1.23 1.42 -13.00 -12.49 -9.95 -13.36
OPM % 0% 0% 3.8% 0.7% 1.3% 1.4% 1.9% -22.7% -25.2% -17% -19.9%
Profit Before Tax + 0.00 0.04 3.93 0.58 1.20 1.37 1.63 -13.00 -12.47 -9.84 -13.27
Tax Expense 0.00 -0.46 0.40 -2.10 -1.49 0.08 1.58 0.80 -5.12 0.00 0.15
Tax % - -1091.1% 10.1% -359.2% -124.2% 5.9% 96.4% - - - -
Profit After Tax 0.00 0.50 3.53 2.68 2.69 1.29 0.06 -13.80 -7.35 -9.84 -13.42
EPS (Basic) 0.00 0.31 2.23 1.70 1.70 0.81 0.04 -8.72 -4.64 -6.21 -8.48

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024
Revenue from Operations 232.13 318.23 368.59
YOY Revenue Growth % -27.06% -13.66% -
Other Income 0.76 0.50 0.10
Total Income 232.90 318.73 368.69
Total Expenses + 281.47 313.95 379.77
Cost of Materials Consumed 124.79 170.56 224.76
Employee Benefit Expense 33.79 40.59 39.07
Other Expenses 56.37 74.45 67.61
Operating Profit -49.33 4.28 -11.17
OPM % -21.3% 1.3% -3%
Profit Before Exceptional -48.57 4.79 -11.07
Exceptional Items 0.00 0.00 0.00
Profit Before Tax + -48.57 4.79 -11.07
Tax Expense -4.17 -1.93 -2.00
Tax % - -40.4% -
Profit After Tax -44.40 6.72 -9.07
EPS (Basic) -28.05 4.25 -5.73

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024
ASSETS
Non-Current Assets + 159.26 167.44 157.70
Property, Plant & Equipment 115.68 133.60 104.19
Capital Work in Progress 0.00 0.00 0.00
Non-Current Investments 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00
Other Intangible Assets 39.40 29.14 20.78
Current Assets + 155.71 198.98 175.72
Inventories 102.77 138.80 123.64
Trade Receivables 40.30 39.07 27.94
Cash and Cash Equivalents 0.70 2.59 0.90
Current Investments 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 103.06 148.98 135.79
Equity Share Capital 15.83 15.83 15.83
Other Equity 87.23 133.15 119.96
Non-Current Liabilities 15.33 25.84 33.85
Current Liabilities 196.58 191.60 163.79
Total Liabilities 211.91 217.44 197.63

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024
Cash from Operating Activities 4.18 42.59 -11.07
Cash from Investing Activities -11.72 -19.47 0.00
Cash from Financing Activities 5.66 -21.71 0.00
Net Increase/Decrease in Cash -1.89 1.41 -11.07